Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01206374 · ClinicalTrials.gov registry record
Questionnaire and Laboratory Data on Vitiligo Vulgaris
A clinical trial, sponsored by St. Luke's-Roosevelt Hospital Center.
- Completed
- Registry status
- 57
- Enrollment target
NCT01206374 is a clinical trial that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 57 participants.
The verdict
NCT01206374 has completed, sponsored by St. Luke's-Roosevelt Hospital Center.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2010-08 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01206374
The ClinicalTrials.gov registry entry for NCT01206374 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's-Roosevelt Hospital Center, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01206374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01206374 about?
NCT01206374 is a clinical study titled "Questionnaire and Laboratory Data on Vitiligo Vulgaris". Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for d...
What is the current status of trial NCT01206374?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2010-08. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT01206374?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.